CompletedNot Applicable

Eye Movement and Cognitive Dysfunction

China1,539 participantsStarted 2020-09-01

Plain-language summary

There is association between eye movement disorder and cognitive dysfunction. Therefore, utilizing eye movement and screening for cognitive dysfunction is feasible. In the present study, the investigators will develop an artificial intelligence platform to screening for cognitive dysfunction by inspecting the function of eye movement. Futher more, based on the screening results, the platform will offer referral suggestions.

Who can participate

Age range45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ①Subjects who are diagnosed as mild cognitive decline, Alzheimer's disease, Vascular dementia, Lewy body dementia, Frontotemporal dementia, other dementia and normal by neurologist. * ②Subjects who can cooperate with the inspection. * ③Subjects who agree to participate in the study and sign the consent form Exclusion Criteria: * ①Subjects who cannot do the inspection. * ②Subjects who suffer from diseases that compromise the inspection.

What they're measuring

Area under the curve

Timeframe: up to 1 month

Trial details

NCT IDNCT04236375

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-30

View on ClinicalTrials.gov More Eye Movement Disorder trials